| Literature DB >> 31861633 |
Joice Guileine Nkuimi Wandjou1, Serena Mevi1, Gianni Sagratini1, Sauro Vittori1, Stefano Dall'Acqua2, Giovanni Caprioli1, Giulio Lupidi1, Giacomo Mombelli3, Sabrina Arpini3, Pietro Allegrini3, Francisco Les4,5, Víctor López4,5, Filippo Maggi1.
Abstract
This study was undertaken to evaluate the nutraceutical potential of the Mela Rosa dei Monti Sibillini (MR), an ancient apple variety of the Sibillini Mountains, central Italy. The chemical profile of the apple's polyphenolic-rich extract (MRE) obtained from first- and second-choice samples using the Amberlite® XAD7HP resin was analyzed by High Performance Liquid Chromatography with Diode-Array and Mass spectrometry (HPLC-DAD-MS) and 21 phytochemicals were quali-quantitatively determined. For comparative purposes, the polyphenol-rich extract of Annurca (ANE), a southern Italian variety, was analyzed. The antioxidant capacity of MREs was evaluated by Folin-Ciocalteu, 1, 1-diphenyl-2-picrylhydrazyl (DPPH), and 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assays. The inhibitory capacity of MREs for the enzymes α-glucosidase, lipase, monoamine oxidase A, tyrosinase, and acetylcholinesterase was also determined. The MREs showed higher polyphenolic and triterpene profiles than the ANE. Their radical scavenging activity was higher than that of ANE and comparable to the reference trolox. The MRE from the second-choice apples displayed higher contents of the 21 phytochemicals investigated. Either MRE from second-choice or first-choice samples showed enzymatic inhibition with IC50 values higher than those of reference inhibitors but worthy of nutraceutical consideration. Taken together, these results show the potential of MRE as a source of bioactive compounds to be used for pharmaceutical, nutraceutical, and cosmeceutical applications has been confirmed.Entities:
Keywords: HPLC; antioxidant; apple polyphenol-rich extract; enzyme inhibition; functional foods
Year: 2019 PMID: 31861633 PMCID: PMC7020459 DOI: 10.3390/plants9010009
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1The Mela Rosa dei Monti Sibillini during its traditional storage at ambient temperature.
Polyphenolic and triterpene compositions (expressed in mg/kg and %) of the purified apple polyphenolic-rich extracts. Note: MRE = polyphenolic-rich extract of Mela Rosa dei Monti Sibillini; ANE = polyphenol-rich extract of Annurca; RT = Retention time; λ = wavelength; SD = standard deviation; RSD = relative standard deviation.
| MRE | ANE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| First-Choice | Second-Choice | ||||||||||
| RT | λ | ||||||||||
| Compounds (mg/kg) | Mean | SD | RSD% | Mean | SD | RSD% | Mean | SD | RSD% | ||
|
| |||||||||||
| Gallic acid | 5.9 | 272 | 64.5 | 1.9 | 3.0 | 40.6 | 1.4 | 3.4 | 70.8 | 7.6 | 10.7 |
|
| |||||||||||
| Catechin | 17.6 | 280 | 20,914.5 | 353.9 | 1.7 | 13,397.9 | 357.8 | 2.7 | 4667.7 | 675.9 | 14.5 |
| Epicatechin | 23.9 | 280 | 38,754.3 | 7686.1 | 19.8 | 42,925.6 | 73.0 | 0.2 | 12,303.2 | 387.3 | 3.1 |
| Procianidin B2 | 24.3 | 230 | 21,692.8 | 251.3 | 1.2 | 30,747.9 | 171.8 | 0.6 | 13,123.0 | 207.4 | 1.6 |
| Procianidin A2 | 29.9 | 230 | 5948.8 | 59.7 | 1.0 | 1456.5 | 37.0 | 2.5 | 1709.9 | 97.0 | 5.7 |
|
| |||||||||||
| Cyanidin 3-glucoside | 25.8 | 520 | 44.9 | 2.4 | 5.4 | 85.1 | 4.4 | 5.1 | 798.6 | 8.1 | 1.0 |
|
| |||||||||||
| Rutin | 31.47 | 265 | 14,172.9 | 378.1 | 2.7 | 17,390.6 | 215.5 | 1.2 | 4596.1 | 248.7 | 5.4 |
| Quercetin 3-D-galactoside | 32 | 265 | 4760.3 | 26.2 | 0.6 | 4601.6 | 120.3 | 2.6 | 4284.2 | 158.3 | 3.7 |
| Kampferol-3-glucoside | 33.6 | 265 | 3518.8 | 35.2 | 1.0 | 2531.4 | 141.2 | 5.6 | 3582.7 | 85.6 | 2.4 |
| Quercetin | 35.8 | 365 | 18.7 | 0.7 | 3.9 | 220.7 | 3.9 | 1.8 | 582.0 | 35.6 | 6.1 |
| Kampferol | 37.8 | 365 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
| |||||||||||
| Neochlorogenic acid | 10.58 | 325 | 325.9 | 1.0 | 0.3 | 166.5 | 8.7 | 5.2 | 637.8 | 52.3 | 8.2 |
| Chlorogenic acid | 22.3 | 325 | 31,786.1 | 660.6 | 2.1 | 34,787.4 | 358.2 | 1.0 | 65,753.3 | 1125.5 | 1.7 |
| Caffeic acid | 22.9 | 325 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 28.9 | 325 | 0.0 | 0.0 | 0.0 | 70.7 | 9.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 30.5 | 325 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
|
| |||||||||||
| Phloridzin | 32.7 | 280 | 18,714.3 | 552.1 | 3.0 | 22,066.9 | 8.2 | 0.0 | 6011.9 | 357.0 | 5.9 |
| Phloretin | 36.3 | 280 | 37.4 | 1.0 | 2.6 | 89.1 | 8.6 | 9.6 | 38.1 | 2.9 | 7.7 |
|
| 160,754.1 | 170,578.5 | 118,159.3 | ||||||||
|
| |||||||||||
| Annurcoic acid | 43.1 | 210 | 17,262.3 | 610.8 | 3.5 | 23,293.5 | 111.1 | 0.5 | 15,382.9 | 1273.2 | 8.3 |
| Oleanolic acid | 45.8 | 210 | 7611.4 | 76.0 | 1.0 | 8449.3 | 574.6 | 6.8 | 8727.6 | 32.6 | 0.4 |
| Ursolic acid | 45.9 | 210 | 18,097.4 | 428.8 | 2.4 | 20,571.3 | 193.0 | 0.9 | 18,864.6 | 804.8 | 4.3 |
|
| 42,971.0 | 52,314.1 | 42,975.1 | ||||||||
|
| 203,725.1 | 222,892.6 | 161,134.4 | ||||||||
|
| 20.4 | 22.3 | 16.1 | ||||||||
Antioxidant capacity of the pure dried extract and the purified apple polyphenolic-rich extracts.
| FOLIN | DPPH | ABTS | |||||
|---|---|---|---|---|---|---|---|
| TEAC | IC50 | TEAC | IC50 | ||||
| Samples | mgGAE/g | mgTE/g | mmol TE/g | µg/ML | mgTE/g | mmol TE/g | µg/mL |
| First-choice MRE | 740.0 ± 38.7 | 611.4 | 2.4 | 9.9 ± 0.6 | 682.3 | 2.7 | 6.6 ± 0.3 |
| Second-choice MRE | 547.1 ± 45.0 | 505.8 | 2.0 | 12.0 ± 0.5 | 643.3 | 2.6 | 7.0 ± 0.0 |
| ANE | 517.0 ± 23.1 | 172.6 | 0.7 | 26.4 ± 0.6 | 402.3 | 1.6 | 12.0 ± 0.9 |
| Positive control Trolox | 5.3 ± 1.1 | 4.7 ± 0.2 | |||||
Figure 2MRE purified extracts inhibit biologically relevant enzymes of metabolic disorders: (A) α-glucosidase (α-GLU) inhibition by MREs and acarbose as reference inhibitor; (B) lipase inhibition of both MREs and orlistat as reference inhibitor. All experiments are repeated at least in triplicate, and IC50 values were calculated by non-linear regression.
Figure 3Activity of MREs on enzymes of the CNS: (A) MAO-A inhibition by MREs and clorgyline as reference inhibitor; (B) AChE inhibition by MREs and galantamine as reference inhibitor; (C) TYR inhibition performed by MREs and kojic acid as reference inhibitor. All experiments are repeated at least in triplicate, and IC50 values were calculated by non-linear regression.
IC50 values of the extracts and reference inhibitors calculated by non-linear regression.
| Enzymatic Inhibition Assay | IC50 (µg/mL) | ||
|---|---|---|---|
| First-Choice MRE | Second-Choice MRE | Reference Inhibitor | |
| α-glucosidase | 907.2 | 823.9 ** | 378.9 (Acarbose) |
| Lipase | 1584.9 *** | 844.7 * | 0.8 (Orlistat) |
| MAO-A | 8.03 * | 6.98 * | 0.15 (Clorgyline) |
| AChE | 1259.0 **** | 1430.6 **** | 0.6 (Galantamine) |
| TYR | 586.1 ** | 168.4 # | 3.5 (Kojic acid) |
Significant differences were detected between samples and reference inhibitors using one-way ANOVA and Tukey multiple comparison test. The α-glucosidase assay: ** p < 0.01 (second-choice MRE versus acarbose); lipase assay: *** p < 0.001 (first-choice MRE versus orlistat), * p < 0.05 (second-choice MRE versus orlistat); MAO-A assay: * p < 0.05 (first-choice and second-choice MRE versus clorgyline); AChE assay: **** p < 0.0001 (first-choice and second-choice MRE versus galantamine); TYR assay: ** p < 0.01 (first-choice MRE versus kojic acid), # p < 0.05 (second-choice MRE versus first-choice MRE). Note: MAO-A = monoamine oxidase A; AChE = acetylcholinesterase; TYR = tyrosinase.